Speaker Profile

Ph.D., Data Scientist, Ardigen

Dr. Krzysztof Rataj works at the intersection of medicinal chemistry, biology, imaging and artificial intelligence in the field of drug discovery. He obtained a PhD in Biophysics from Jagiellonian University, and worked on numerous projects in collaboration with scientific teams from Hungary, Denmark and Norway. His team explores the application of artificial intelligence approaches to various aspects of drug design and precision medicine, such as transformers for property prediction and compound optimization, natural language processing methods in protein and nucleic acid research, and computer vision in high content screening and histopathology. Their current endeavor is the marriage of chemical structure and phenotypic screening images in order to create a comprehensive approach to high content screening.

AI & Data Science Showcase:

Ardigen is harnessing advanced AI methods for novel precision medicine. The company’s in-house datasets, together with advanced AI platforms, empower the development of effective therapies.

Enhancing Phenotypic Drug Discovery with AI-based Methods
The resurgence of phenotypic screening as a viable method of early drug discovery opens up a new field for application of AI-based methods. We would like to explore the concept of merging high content image data with chemical compound data to provide new quality in HCS pipelines.

 Session Abstract – PMWC 2022 Silicon Valley

Track 7, June 28-30

The PMWC 2022 AI Company Showcase will provide a 15-minute time slot for selected AI companies to present their latest technologies to an audience of leading investors, potential clients, and partners. We will hear from companies building technologies that expedite the pre-clinical and clinical drug discovery and development process, accelerate patient diagnosis and treatment, or develop scalable systems framework to make AI and deep/machine learning a reality.